Search
Descriptor English: Linagliptin
Descriptor Spanish: Linagliptina
Descriptor linagliptina
Scope note: Derivado de quinazolina y purina que funciona como una INCRETINA e INHIBIDOR DE DIPEPTIDIL-PEPTIDASA. Se utiliza como HIPOGLUCÉMICO en el tratamiento de la DIABETES MELLITUS TIPO II.
Descriptor Portuguese: Linagliptina
Descriptor French: Linagliptine
Entry term(s): BI-1356
BI1356
Tree number(s): D03.633.100.759.562
D03.633.100.786.563
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069476
Scope note: A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Hypoglycemic Agents
Incretins
Dipeptidyl-Peptidase IV Inhibitors
Registry Number: 3X29ZEJ4R2
Related: Phosphate de sitagliptine MeSH
DeCS ID: 55934
Unique ID: D000069476
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/06
Revision Date: 2016/05/31
Linagliptine - Preferred
Concept UI M0554626
Preferred term Linagliptine
BI-1356 - Narrower
Concept UI M0554625
Preferred term BI-1356
Entry term(s) BI1356



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey